Yahoo Finance Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure helps cut through all the noise.
Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.
2 Stocks to Add to Your Watchlist
The Zacks Expected Surprise Prediction, or ESP, works by locking in on the most up-to-date analyst earnings revisions because they can be more accurate than estimates from weeks or even months before the actual release date. The thinking is pretty straightforward: analysts who provide earnings estimates closer to the report are likely to have more information. With this in mind, the Expected Surprise Prediction compares the Most Accurate Estimate (being the most recent) against the overall Zacks Consensus Estimate. The percentage difference provides the ESP figure.
The last thing we will do today, now that we have a grasp on the ESP and how powerful of a tool it can be, is to look at a qualifying stock. Shockwave Medical (SWAV) holds a Zacks Rank #3 at the moment and its Most Accurate Estimate comes in at $1.11 a share 21 days away from its upcoming earnings release on May 13, 2024.
SWAV has an Earnings ESP figure of 7.25%, which, as explained above, is calculated by taking the percentage difference between the $1.11 Most Accurate Estimate and the Zacks Consensus Estimate of $1.04.
SWAV is just one of a large group of Medical stocks with a positive ESP figure. Cigna (CI) is another qualifying stock you may want to consider.
Slated to report earnings on May 2, 2024, Cigna holds a #3 (Hold) ranking on the Zacks Rank, and it's Most Accurate Estimate is $6.20 a share 10 days from its next quarterly update.
Cigna's Earnings ESP figure currently stands at 0.48% after taking the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $6.17.
SWAV and CI's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon.
Find Stocks to Buy or Sell Before They're Reported
Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ShockWave Medical, Inc. (SWAV) : Free Stock Analysis Report
Cigna Group (CI) : Free Stock Analysis Report
